All participants were treated with a flexible GnRH antagonist protocol. Ovarian stimulation was initiated on cycle day 3, with use of daily injections of 150-300IU of gonadotropin, and when dominant follicles grew to 12-14mm, subcutaneously injecting 0.25mg of GnRH antoganist(Cetrotide, Merck-Serono, Switzerland)was used for suppressing LH surge. And 0.2 mg of GnRH-A was injected subcutaneously at 23: 00 on the trigger day. Oocyte retrieval was performed 33-36h later, cumulus–oocyte complexes were collected, and oocytes were denuded (15 (link)).
Free full text: Click here